Andrew Robinson

20.4k citations
137 papers · 13.3k indexed · 5 hit papers · h-index 32

Impact in

  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • CAR-T cell therapy research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 30
    • Colorectal Cancer Treatments and Studies 9
    • Lung Cancer Research Studies 8
    • Lung Cancer Treatments and Mutations 41
    • Lung Cancer Diagnosis and Treatment 23

Andrew Robinson

132 papers receiving 13.0k citations

Hit Papers

Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study 2023 · 233 citations
23320162026201920222.0k4.0k6.0k

Peers

Andrew Robinson
Comparison fields: 5 of 162
  • Oncology 9.3k
  • Pulmonary and Respiratory Medicine 6.2k
  • Immunology 2.1k
  • Cancer Research 1.4k
  • Geophysics 935
Replace Donald E. White with:
Donald E. White United States
Graham Packham United Kingdom
Yanhua Hu China
Kazuhiro Tsukada Japan
Yasuo Ikeda Japan
Michael Bartoň Australia
Fred G. Barker United States
Qing Lan United States
Keisuke Ito Japan
David J. Dunlop Canada
Andrew Robinson relative to Donald E. White United States Donald E. White's profile →
Citations per field
00.5×1.5×2.2×
Donald E. White · 1×
Citations per year

Countries citing papers authored by Andrew Robinson

Since Specialization
Citations

This map shows the geographic impact of Andrew Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Robinson more than expected).

Fields of papers citing papers by Andrew Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Robinson. The network helps show where Andrew Robinson may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Robinson Line = papers co-authored together Andrew Robinson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20243
3
Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
Hit paper breakdown →
2023233
4 20235
5 20231
6 202120
7 20200
8 20202
9 202021
10 20191
11 201910
12 2018156
13 20184
14 2018134
15 20182
16 20184
17 201710
18 20161
19 20152
20 199330

About Andrew Robinson

Andrew Robinson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Geology, Geophysics and Earth-Surface Processes, having authored 137 papers that have together received 13.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Cancer Immunotherapy and Biomarkers (30 papers), Lung Cancer Diagnosis and Treatment (23 papers), Colorectal Cancer Treatments and Studies (9 papers), Testicular diseases and treatments (8 papers), Hydrocarbon exploration and reservoir analysis (8 papers), Lung Cancer Research Studies (8 papers) and Geological and Geochemical Analysis (7 papers). The work is most often cited by research in Oncology (9.3k citations), Pulmonary and Respiratory Medicine (6.2k citations), Immunology (2.1k citations), Cancer Research (1.4k citations) and Geophysics (935 citations). Andrew Robinson has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ali Tafreshi, Rina Hui, Nir Peled, Sinéad Cuffe, Maya Gottfried, Katsuyuki Hotta, Julie R. Brahmer, Tibor Csőszi, Suman Rao and Delvys Rodríguez‐Abreu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Marine and Petroleum Geology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026